Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Health Care Financing Review|March 3, 1997
Consumer perspectives on information needs for health plan choiceD A Gibbs, J A Sangl, B BurrusClinical Psychology Review|September 1, 1999
Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?D M Sheppard, J L Bradshaw, R Purcell, et al.Child Welfare|January 27, 1999
Measuring performance in child welfare: secondary effects of successC L Usher, J B Wildfire, D A GibbsJournal of Acquired Immune Deficiency Syndromes|January 1, 1991
Populations at increased risk of HIV infection: current knowledge and limitationsD A Gibbs, D N Hamill, K Magruder-HabibJournal of Cancer Survivorship : Research and Practice|November 13, 2019
Building a novel occupational rehabilitation program to support cancer survivors to return to health, wellness, and work in AustraliaD M Sheppard, D Frost, M Jefford, et al.Human Genetics|January 1, 1982
Tetraploid conceptus with three paternal contributionsD M Sheppard, R A Fisher, S D Lawler, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 14, 1999
Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorderD M Sheppard, J L Bradshaw, J B Mattingley, et al.Public Health Reports (Washington, D.C. : 1974)|November 1, 1991
Paid advertising for AIDS prevention--would the ends justify the means?R J Donovan, J Jason, D A Gibbs, et al.Clinical Science (London, England : 1979)|June 1, 1980
Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylaseG H Elder, D M Sheppard, R E De Salamanca, et al.Lancet (London, England)|June 11, 1983
Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tardaG H Elder, D M Sheppard, J A Tovey, et al.Pageof 5